Potential Abiomed Class Action

Last Updated on May 1, 2020

Investigation Complete

Comments |

At A Glance

This Alert Affects
Investors who purchased Abiomed common stock.
These investors may have legal recourse to pursue compensation for damages in light of a recent company disclosure.
Abiomed, Inc.
Additional Details
Abiomed is a leading healthcare technology company which has focused itself on developing new technologies to help or replace the pumping function of the heart.
On Nov. 1, 2012, Abiomed issued a press release announcing that the U.S. Attorney's Office for the District of Columbia was investigating the company's marketing and labeling of its Impella 2.5 heart pump system.